Further analyses on GPR39 would enable greater comprehension of HBV replication/pathogenesis and GPCR signaling/networks, serving to create novel HTAs and preventive and therapeutic options for HBV infection and HCC. Here, GPR39 is linked to hepatocellular carcinoma.